Jackie Hunter
From Wikipedia, the free encyclopedia
Professor Jackie Hunter | |
---|---|
Born |
Ann Jackie Hunter[1] 1956 (age 57–58)[2] |
Institutions |
BBSRC Proximagen OI Pharma Partners[2] GlaxoSmithKline Zoological Society of London St George's, University of London |
Alma mater | Bedford College, London |
Thesis | Chemical communication, aggression and sexual behaviour in the owl monkey (Aotus trivirgatus griseimembra) (1981) |
Known for |
Open innovation[3][4] CEO of the BBSRC Innovative Medicines Initiative[2] |
Notable awards |
PhD[5] CBE FBPharmacolS |
Website | |
blogs.bbsrc.ac.uk twitter.com/JHunterBBSRC |
Education
Hunter was educated at Kings School[8] and completed her Bachelor of Science degree and PhD[5] in Psychology at Bedford College, London which is now part of Royal Holloway, University of London. Her PhD thesis was on the psychology of owl monkeys (genus Aotus).[5]
Career
Following her PhD, Hunter undertook a Wellcome Trust Postdoctoral research fellowship at St George’s Hospital Medical School before joining the pharmaceutical industry where she worked for 25 years for GSK, Proximagen and OI Pharma Partners.[3][4][9][10][11][12][13][14] She became Chief Executive Officer (CEO) of the BBSRC in 2013.[6][15][16]
Awards
In 2010 Hunter was awarded the CBE for services to the pharmaceutical industry. She is also a Fellow of the British Pharmacological Society.
References
- ↑ Jackie Hunter from the Scopus bibliographic database
- ↑ 2.0 2.1 2.2 "Royal Holloway, University of London Dr Jackie Hunter CBE (1956-)". Archived from the original on 2013-11-11.
- ↑ 3.0 3.1 "OI Pharma Partners - Open Innovation in Healthcare". Archived from the original on 2013-11-08.
- ↑ 4.0 4.1 4.2 "Chief Executive's biography: Professor Jackie Hunter". Archived from the original on 2013-11-08.
- ↑ 5.0 5.1 5.2 5.3 Hunter, A. Jackie (1981). Chemical communication, aggression and sexual behaviour in the owl monkey (Aotus trivirgatus griseimembra) (PhD thesis). Bedford College, London.
- ↑ 6.0 6.1 Jackie Hunter to be next BBSRC chief, Times Higher Education, 2013-06-04
- ↑ Jackie Hunter on Twitter
- ↑ "Jackie Hunter PhD CBE FBPharmacolS LinkedIn profile". Archived from the original on 2013-11-08.
- ↑ Hunter, J. (2011). "Challenges for pharmaceutical industry: New partnerships for sustainable human health". Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 369 (1942): 1817–1825. doi:10.1098/rsta.2010.0377.
- ↑ Hagan, J. J.; Leslie, R. A.; Patel, S.; Evans, M. L.; Wattam, T. A.; Holmes, S.; Benham, C. D.; Taylor, S. G.; Routledge, C.; Hemmati, P.; Munton, R. P.; Ashmeade, T. E.; Shah, A. S.; Hatcher, J. P.; Hatcher, P. D.; Jones, D. N.; Smith, M. I.; Piper, D. C.; Hunter, A. J.; Porter, R. A.; Upton, N. (1999). "Orexin a activates locus coeruleus cell firing and increases arousal in the rat". Proceedings of the National Academy of Sciences of the United States of America 96 (19): 10911–10916. doi:10.1073/pnas.96.19.10911. PMC 17982. PMID 10485925.
- ↑ Rogers, D. C.; Fisher, E. M.; Brown, S. D.; Peters, J.; Hunter, A. J.; Martin, J. E. (1997). "Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment". Mammalian genome : official journal of the International Mammalian Genome Society 8 (10): 711–713. doi:10.1007/s003359900551. PMID 9321461.
- ↑ Piper, D. C.; Upton, N.; Smith, M. I.; Hunter, A. J. (2000). "The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats". The European journal of neuroscience 12 (2): 726–730. doi:10.1046/j.1460-9568.2000.00919.x. PMID 10712652.
- ↑ Brown, S. D. M.; Peters, P. M.; Strivens, J.; Rogers, M.; Hagan, D.; Spurr, J.; Gray, N.; Vizor, I. C.; Brooker, L.; Whitehill, D.; Washbourne, E.; Hough, R.; Greenaway, T.; Hewitt, S.; Liu, M.; McCormack, X.; Pickford, S.; Selley, K.; Wells, R.; Tymowska-Lalanne, C.; Roby, Z.; Glenister, P.; Thornton, P.; Thaung, C.; Stevenson, C.; Arkell, J. A.; Mburu, R.; Hardisty, P.; Kiernan, R.; Erven, A. (2000). "A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse". Nature Genetics 25 (4): 440–443. doi:10.1038/78140. PMID 10932191.
- ↑ Piper, D. C.; Upton, N.; Smith, M. I.; Hunter, A. J. (2000). "The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats". European Journal of Neuroscience 12 (2): 726–730. doi:10.1046/j.1460-9568.2000.00919.x. PMID 10712652.
- ↑ "Bioscience innovation leader appointed as next BBSRC Chief Executive". Archived from the original on 2013-11-08.
- ↑ "Press release: New chief executive for the Biotechnology and Biological Sciences Research Council". Archived from the original on 2013-11-08.
Government offices | ||
---|---|---|
Preceded by Douglas Kell |
CEO of the Biotechnology and Biological Sciences Research Council 2013–present |
Incumbent |
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.